Search for: "EVALUATION & TESTING ASSOCIATES, INC."
Results 161 - 180
of 1,195
Sorted by Relevance
|
Sort by Date
28 Apr 2020, 4:20 am
By a vote of 6-3, the court dismissed as moot a Second Amendment challenge to New York City’s now-repealed limits on transporting personal firearms, in New York State Rifle & Pistol Association Inc. v. [read post]
12 Sep 2018, 12:51 pm
Venable clients that engage in selling goods and/or services over the internet should evaluate whether the recent Supreme Court decision in South Dakota v. [read post]
4 Jan 2019, 4:14 am
., who until now recused himself in a pending copyright case, Rimini Street Inc. v. [read post]
9 Aug 2016, 12:44 am
Group Long Term Disability Plan for Employees of Oracle America, Inc. [read post]
10 Feb 2022, 2:42 pm
Six cases were pregnancy-associated, with two resulting in fetal loss. [read post]
8 Oct 2022, 9:03 pm
— OPINION — By Jayne Roth, M.P.H, REHSRimkus Consulting Group, Inc. [read post]
13 Jul 2020, 1:13 pm
Barr Labs., Inc. [read post]
8 Jun 2023, 11:16 am
New York Shipping Association (A-19-22) (087217) Argued April 25, 2023 -- Decided June 5, 2023SABATINO, P.J.A.D. [read post]
3 Aug 2023, 2:32 pm
Earlier Test: Lutheran Heritage The Board in Martin Luther Memorial Home, Inc. d/b/a Lutheran Heritage Village-Livonia, 343 NLRB No. 75 (2004) set forth a three-prong test in evaluating work rules. [read post]
23 Apr 2012, 3:30 am
Ass’n, Inc. v. [read post]
10 Jul 2020, 1:36 pm
See the following press releases for complete details on the recalled products: Fresh Express Hy-Vee Inc. [read post]
6 Dec 2009, 2:47 pm
Indeed, the district court erred on evaluating the remaining two disputed factors: (1) intent to create an association and (2) evidence of actual association. [read post]
28 Jun 2014, 11:39 pm
Risks associated with ReWalk include pressure sores, bruising or abrasions, falls and associated injuries, and diastolic hypertension during use.The FDA reviewed the ReWalk through its de novo classification process, a regulatory pathway for novel, first-of-its-kind medical devices that are generally low-to moderate-risk. [read post]
27 Feb 2018, 9:12 am
Relevant parts of this April 9, 2013 letter from Novartis Pharmaceuticals Canada Inc. are set forth below: Dear Healthcare Professional: Subject: Updated information regarding the possible risk of developing atherosclerosis-related diseases with the use of TASIGNA* (nilotinib) Novartis Pharmaceuticals Canada Inc. [read post]
28 May 2015, 2:29 pm
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579, 593 (1993). [read post]
4 Aug 2012, 5:08 am
For a free case evaluation, call 1-800-632-1404. [read post]
10 Aug 2012, 7:27 am
For a free case evaluation, call 1-800-632-1404. [read post]
12 Dec 2011, 11:14 am
Telemarketing Associates, Inc., 538 U.S. 600, 612 (2003) (relying in part on Gertz’s holding that “the ‘intentional lie’ is ‘no essential part of any exposition of ideas’” in concluding that fraud is constitutionally unprotected); see also, e.g., Herbert v. [read post]
12 Dec 2011, 11:14 am
Telemarketing Associates, Inc., 538 U.S. 600, 612 (2003) (relying in part on Gertz’s holding that “the ‘intentional lie’ is ‘no essential part of any exposition of ideas’” in concluding that fraud is constitutionally unprotected); see also, e.g., Herbert v. [read post]
11 Jun 2021, 7:42 pm
FDA issued an assignment to follow-up at the associated firms. [read post]
